Adoptive transfer of T regulatory cells (Tregs) is of great interest as a novel
immunosuppressive therapy in autoimmune disorders and transplantation. Obtaining a …

The concept of regulatory T cell (Treg)-based immunotherapy has enormous potential for
facilitating tolerance in autoimmunity and transplantation. Clinical translation of Treg cell …

Adoptive cell therapy is an emerging treatment strategy for a number of serious diseases.
Regulatory T (Treg) cells represent 1 cell type of particular interest for therapy of …

The last few decades, an intense interest has been developed in using regulatory T cells
(Tregs) for immunotherapy by the biomedical community, depending on the facts that Tregs …

Regulatory T cells (Tregs) are a unique subset of lymphocytes that play a vital role in
regulating the immune system by suppressing unwanted immune responses and thus …

Regulatory T cell (Treg)-based immunotherapy is of great interest to induce tolerance in
clinical transplantation settings. In fact, the first clinical trials of Treg infusion after stem cell …

In recent years, the exploration of regulatory T cell (Treg)-based cellular therapy has
become an attractive strategy to ameliorate inflammation and autoimmunity in various …

Background aims Regulatory T cells (Tregs) are the main mediators of peripheral tolerance.
Treg-directed therapy has shown promising results in preclinical studies of diverse …

Regulatory T (Treg) cells are a heterogenous population of immunosuppressive T cells
whose therapeutic potential for the treatment of autoimmune diseases and graft rejection is …

Background aims Mouse models indicate that adoptive transfer of regulatory T cells (Treg)
may suppress graft-versus-host-disease (GvHD) while preserving graft-versus-leukemia …